121 related articles for article (PubMed ID: 31761727)
1. Synthesis and characterization of
Kim H; Koo HJ; Ahn J; Kim JY; Choi JY; Lee KH; Kim BT; Choe YS
Bioorg Med Chem; 2020 Jan; 28(1):115212. PubMed ID: 31761727
[TBL] [Abstract][Full Text] [Related]
2. 64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis.
Kang CM; Koo HJ; Lee S; Lee KC; Oh YK; Choe YS
Nucl Med Biol; 2013 Nov; 40(8):1018-24. PubMed ID: 24035550
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Rajabi M; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
[TBL] [Abstract][Full Text] [Related]
4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
5. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Yalcin M; Dyskin E; Lansing L; Bharali DJ; Mousa SS; Bridoux A; Hercbergs AH; Lin HY; Davis FB; Glinsky GV; Glinskii A; Ma J; Davis PJ; Mousa SA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1972-80. PubMed ID: 20133461
[TBL] [Abstract][Full Text] [Related]
6. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.
Kimura RH; Cheng Z; Gambhir SS; Cochran JR
Cancer Res; 2009 Mar; 69(6):2435-42. PubMed ID: 19276378
[TBL] [Abstract][Full Text] [Related]
7. A dual-labeled knottin peptide for PET and near-infrared fluorescence imaging of integrin expression in living subjects.
Kimura RH; Miao Z; Cheng Z; Gambhir SS; Cochran JR
Bioconjug Chem; 2010 Mar; 21(3):436-44. PubMed ID: 20131753
[TBL] [Abstract][Full Text] [Related]
8. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
9. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
[TBL] [Abstract][Full Text] [Related]
10. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
11. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
12. Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.
Yalcin M; Lin HY; Sudha T; Bharali DJ; Meng R; Tang HY; Davis FB; Stain SC; Davis PJ; Mousa SA
Horm Cancer; 2013 Jun; 4(3):176-85. PubMed ID: 23456390
[TBL] [Abstract][Full Text] [Related]
13. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
[No Abstract] [Full Text] [Related]
14. Catabolism of (64)Cu and Cy5.5-labeled human serum albumin in a tumor xenograft model.
Kang CM; Kim H; Koo HJ; Park JW; An GI; Choi JY; Lee KH; Kim BT; Choe YS
Amino Acids; 2016 Jul; 48(7):1667-75. PubMed ID: 27098932
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of MR-49, a deiodinated analog of tetraiodothyroacetic acid (tetrac), as a novel pro-angiogenesis modulator.
Rajabi M; Sudha T; Darwish NH; Davis PJ; Mousa SA
Bioorg Med Chem Lett; 2016 Aug; 26(16):4112-6. PubMed ID: 27381084
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
18. PET of vascular endothelial growth factor receptor expression.
Cai W; Chen K; Mohamedali KA; Cao Q; Gambhir SS; Rosenblum MG; Chen X
J Nucl Med; 2006 Dec; 47(12):2048-56. PubMed ID: 17138749
[TBL] [Abstract][Full Text] [Related]
19. Tetrac-conjugated polymersomes for integrin-targeted delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Rezvani R; Farzad SA; Taghdisi SM; Abnous K; Ramezani M
Int J Pharm; 2017 Oct; 532(1):581-594. PubMed ID: 28935257
[TBL] [Abstract][Full Text] [Related]
20. A vascular endothelial growth factor 121 (VEGF(121))-based dual PET/optical probe for in vivo imaging of VEGF receptor expression.
Kang CM; Koo HJ; Lee KC; Choe YS; Choi JY; Lee KH; Kim BT
Biomaterials; 2013 Sep; 34(28):6839-45. PubMed ID: 23787114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
